These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17188522)

  • 1. Stable expression of adenylyl cyclase 2 leads to the functional rescue of human 5-HT6 receptor in a CHODUKX cell line.
    Nawoschik SP; Olsen M; Smith DL; Khawaja X
    J Pharmacol Toxicol Methods; 2007; 55(3):323-31. PubMed ID: 17188522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
    Adham N; Zgombick JM; Bard J; Branchek TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
    Krobert KA; Andressen KW; Levy FO
    Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of a 5-HT7 receptor positively coupled to adenylate cyclase activation in human granulosa-lutein cells.
    Graveleau C; Paust HJ; Schmidt-Grimminger D; Mukhopadhyay AK
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1277-86. PubMed ID: 10720076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.
    Krobert KA; Levy FO
    Br J Pharmacol; 2002 Mar; 135(6):1563-71. PubMed ID: 11906971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.
    Mialet J; Berque-Bestel I; Eftekhari P; Gastineau M; Giner M; Dahmoune Y; Donzeau-Gouge P; Hoebeke J; Langlois M; Sicsic S; Fischmeister R; Lezoualc'h F
    Br J Pharmacol; 2000 Feb; 129(4):771-81. PubMed ID: 10683202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
    Zgombick JM; Schechter LE; Adham N; Kucharewicz SA; Weinshank RL; Branchek TA
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways.
    Romero G; Sánchez E; Pujol M; Pérez P; Codony X; Holenz J; Buschmann H; Pauwels PJ
    Br J Pharmacol; 2006 Aug; 148(8):1133-43. PubMed ID: 16865095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
    Thomas DR; Gittins SA; Collin LL; Middlemiss DN; Riley G; Hagan J; Gloger I; Ellis CE; Forbes IT; Brown AM
    Br J Pharmacol; 1998 Jul; 124(6):1300-6. PubMed ID: 9720804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.
    Mialet J; Berque-Bestel I; Sicsic S; Langlois M; Fischmeister R; Lezoualc'h F
    Br J Pharmacol; 2000 Oct; 131(4):827-35. PubMed ID: 11030734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human 5-HT4(d) receptor desensitization in CHO cells.
    Mialet J; Fischmeister R; Lezoualc'h F
    Br J Pharmacol; 2003 Feb; 138(3):445-52. PubMed ID: 12569069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells.
    Wang Y; Kong Y; Shei GJ; Kang L; Cvijic ME
    Assay Drug Dev Technol; 2011 Oct; 9(5):522-31. PubMed ID: 21561374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase.
    Varrault A; Journot L; Audigier Y; Bockaert J
    Mol Pharmacol; 1992 Jun; 41(6):999-1007. PubMed ID: 1614416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of adenylyl cyclase by endogenous G(s)-coupled receptors in human embryonic kidney 293 cells is attenuated by 5-HT(7) receptor expression.
    Andressen KW; Norum JH; Levy FO; Krobert KA
    Mol Pharmacol; 2006 Jan; 69(1):207-15. PubMed ID: 16189297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
    Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
    Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
    Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P
    Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
    Unsworth CD; Molinoff PB
    J Pharmacol Exp Ther; 1994 Apr; 269(1):246-55. PubMed ID: 8169832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
    Krobert KA; Bach T; Syversveen T; Kvingedal AM; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):620-32. PubMed ID: 11414657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.